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Background: To achieve full benefits of vaccination programmes, high uptake and timely receipt of vac-
cinations are required.
Objectives: To examine uptake and timeliness of infant and pre-school booster vaccines using cohort
study data linked to health records.
Methods: We included 1782 children, born between 2000 and 2001, participating in the Millennium
Cohort Study and resident in Wales, whose parents gave consent for linkage to National Community
Child Health Database records at the age seven year contact. We examined age at receipt, timeliness of
vaccination (early, on-time, delayed, or never), and intervals between vaccine doses, based on the recom-
mended schedule for children at that time, of the following vaccines: primary (diphtheria, tetanus, per-
tussis (DTP), polio, Meningococcal C (Men C), Haemophilus influenzae type b (Hib)); first dose of measles,
mumps and rubella (MMR); and pre-school childhood vaccinations (DTP, polio, MMR). We compared par-
ental report with child health recorded MMR vaccination status at age three years.
Results: While 94% of children received the first dose of primary vaccines early or on time, this was lower
for subsequent doses (82%, 65% and 88% for second and third doses and pre-school booster respectively).
Median intervals between doses exceeded the recommended schedule for all but the first dose with
marked variation between children. There was high concordance (97%) between parental reported and
child health recorded MMR status.
Conclusions: Routine immunisation records provide useful information on timely receipt of vaccines and
can be used to assess the quality of childhood vaccination programmes. Parental report of MMR vaccine
status is reliable.
 2017 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
To achieve their full benefit, timely delivery of vaccines as well
as high uptake are required [1]. The timeliness of vaccinations, that
is vaccination at the earliest appropriate age, should be an impor-
tant public health goal, and yet this information is often lacking as
coverage is the usual metric used. Children receiving vaccinations
late remain susceptible to vaccine preventable diseases: this may
jeopardise their own health, as well as that of younger siblings
and compromise herd immunity with consequent potential risk
of disease outbreaks. Conversely, vaccines given too early or with
a shortened interval between doses may result in a suboptimalimmune response, leading to a false sense of protection. Timely
immunisation is important to protect against infections with peaks
in incidence or particular severity in the very young, for example
pertussis, meningococcal B and Haemophilus influenzae type b.
Vaccination timeliness has been investigated in the USA, New
Zealand, Australia, Belgium, Sweden and low income country set-
tings, but there is a paucity of published research in the UK. In Aus-
tralia, vaccination delays were more common for later doses and
for vaccines given at an older age [2]. In the USA, only a quarter
of children received all vaccines according to recommended immu-
nisation schedules [3]. Luman found that timeliness varied signifi-
cantly by vaccine type: 5–14% of children had received vaccines
too early to be considered effective [4,5]. In Belgium up to 32% of
infants experienced delay in receiving the first dose of measles,
mumps and rubella (MMR) vaccine and 95% for the third dose of
diphtheria, tetanus and pertussis (DTP) vaccine [6].
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ally for the routine vaccines for children reaching the ages of one,
two and five years in the relevant evaluation period [7]. Although
valuable for monitoring trends, these data give no insight into
whether vaccines were given on time according to the schedule.
For example, a fully vaccinated two year old child may actually
have been under-vaccinated for a considerable period of that time.
High overall coverage has been achieved in the UK, but persisting
inequalities leave gaps in immunity. Exploring vaccine timeliness
and ensuring timely vaccine delivery may help to address these
inequalities.
Previous research based on parental report of immunisation
status found high vaccine uptake among participants in the Millen-
nium Cohort Study (MCS) [8–10]. In this study we linked routine
child health vaccination records to children’s MCS data to establish
the timeliness of vaccine receipt in relation to recommendations in
place at that time, with the objective of understanding the preva-
lence and distribution of delayed primary and pre-school vaccina-
tions in a large nationally representative sample of children.
Additionally, we compared parental report of their child’s MMR
vaccination status with that routinely recorded in child health
systems.2. Methods
2.1. Study population
We used data from the MCS, a UK-wide nationally representa-
tive birth cohort comprising 18,818 children from 18,552 families
born between September 2000 and January 2002. Parents were
interviewed at home when their child was aged nine months and
subsequently at three, five, seven, eleven and fourteen years of
age. At the age seven home visit, written consent was sought from
parents to link MCS information collected until each child’s 14th
birthday, to data routinely collected by government departments
or agencies, and other public sector organisations. The Northern
and Yorkshire Research Ethics Committee gave approval for the
MCS age seven survey; no additional approval was needed for this
linked data analysis which focusses on those resident in Wales.
Parents of 1840 (94.3%) of 1951 singletons resident in Wales, con-
sented to health record linkage. Linked MCS and National Commu-
nity Child Health Database (NCCHD) records were available for
1831 children. We excluded 46 children interviewed in countries
other than Wales on one or more occasions by age 11 years and
three for whom the main respondent was not the natural mother
at the first interview, leaving a final sample of 1782.Table 1
Vaccine schedule and definitions used for timeliness of vaccinations.
Vaccines Vaccine doses due
on the same occasion
Due at age
Primary vaccines:
Diphtheria, Tetanus and Pertussis
Haemophilus influenzae type b
Oral Polio
Meningococcal group C
DTP 1, Hib 1, Polio 1, Men C 1 8 weeks
DTP 2, Hib 2, Polio 2, Men C 2 12 weeks
DTP 3, Hib 3, Polio 3, Men C 3 16 weeks
Measles, Mumps and Rubella MMR 1 1 year
Pre-school boosters:
Diphtheria, Tetanus and Pertussis
Polio - oral or inactivated
Measles,
Mumps and Rubella
DTP PSB, Polio PSB, MMR 2 3 years, 4
months2.2. Record linkage
We accessed coded data from the NCCHD, which brings
together data from local child health system databases held by
NHS organisations and includes information from birth registra-
tions, child health examinations and immunisations.
We used the privacy-protecting Secure Anonymised Informa-
tion Linkage (SAIL) Databank to store and access our data. Datasets
imported into SAIL are anonymised and linked using a split file
process preventing access to both identifiable data and clinical
information at the same time. Records are linked through assigning
unique encrypted Anonymised Linkage Fields (ALF) to person-
based records [11].2.3. Parental report of MMR vaccination
We compared parental response to the question ‘‘Has ^[cohort
member] had any vaccination against measles, mumps or rubella
(including MMR)?” asked at the age three interview, to NCCHD
records of MMR vaccination, taking into account the age of the
child at the interview and at MMR vaccination.2.4. Timeliness of vaccinations
Vaccination schedules for the UK have changed repeatedly over
the years. Children born in Wales between August 2000 and
November 2001 should have received routine vaccinations as
shown in Table 1. This cohort of children received separate DTP,
polio, and Hib vaccines rather than the combination DTaP/IPV/
Hib (5-in-1 vaccine) introduced in 2004. Although we considered
analysing these vaccines as if they were a combination, a few chil-
dren didn’t receive all the vaccines or received them on different
dates, so we considered each vaccine separately.
Timeliness of vaccination was classified as early, on-time,
delayed, or never, based on the recommended vaccination sched-
ule. For the primary vaccines (diphtheria, tetanus, pertussis
(DTP); oral polio vaccine; Haemophilus influenzae type b (Hib);
Meningococcal C (Men C)) we defined a vaccine as being given
‘on time’ if given in the interval between the age when the vaccine
was due and the age when the next dose was due; ‘early’ as being
given prior to these ages; and ‘delay’ when given after the latest ‘on
time’ ages (Table 1). For MMR and pre-school boosters, ‘on time’
was defined as 12–15 months and three years four months to five
years respectively.
Child’s date of birth was supplied as week of birth (set to the
Monday) and a day of birth within that week was assigned by add-Timeliness of vaccination based on age at which vaccine received
Early On time Delayed Never
<8 weeks 8–12 weeks >12 weeks Not at all
<12 weeks 12–16 weeks >16 weeks Not at all
<16 weeks 16–20 weeks >20 weeks Not at all
<12 months 12–15 months >15
months
Not at all
<3 years, 4
months
3 years, 4 months to 5
years
>5 years Not at all
7168 S. Walton et al. / Vaccine 35 (2017) 7166–7173ing a uniform random number between 0 and 6 days. Age at vacci-
nation was calculated using this date and date of vaccination.2.5. Statistical analysis
All analyses were performed using StataSE 13 (StataCorp. 2013.
Stata Statistical Software: Release 13. College Station, TX: Stata-
Corp LP.). Survey and non-response weights at age seven years
were used to adjust for clustered sampling design, data missing
due to losses to follow-up, and lack of consent to linkage. Weighted
percentages were calculated and reported. Chi-squared tests were
used to explore factors associated with delayed receipt of the first
dose of DTP.
If there was uncertainty about receipt of a vaccine dose due to
errors in the NCCHD records, participants (max n = 2) were omitted
from the specific analysis involved.3. Results
3.1. Characteristics of the cohort
We included 1782 children in this analysis (919; 51.6% boys).
The majority (97.2%) was of a white ethnic origin. At the firstFig. 1. Timeliness of vaccinations (A) Polio vacciMCS interview, 1233 (69.2%) lived in ‘disadvantaged’ and 549 in
‘advantaged’ electoral wards, with 1350 (75.8%) living in urban
and 432 in rural areas. (Disadvantaged wards were oversampled
[12] but the weights adjusted analyses making results nationally
representative.)
3.2. Concordance between parental report and routinely recorded
vaccination status
Parental report (99.1% mothers, 0.7% fathers, 0.1% grandmoth-
ers) of the first dose of MMR was compared with NCCHD MMR
records. Taking into account when MMR vaccines were received
in relation to the date of the MCS interview, at the time of the
MCS age three interview, 89.8% of parental reports and 89.1% of
NCCHD records (weighted percentages) suggested that children
had received the first dose of MMR. The concordance between par-
ental report and NCCHD record of MMR status was very high (97%)
(Appendix 1).
In the MCS, when parents consulted the personal child health
record (PCHR) to answer vaccination questions and information
was available (n = 241), there were only three (1.2%) discrepancies
between parental report of MMR status and the NCCHD record
whereas when parents did not consult the PCHR (n = 1390), there
were 45 (3.2%) discrepancies.nations (B) DTP 1 and MMR 1 vaccinations.
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The proportion receiving vaccines early or on time, decreased
by dose as illustrated for polio (Fig. 1A); 79.6% of infants received
the first dose on time but only 59.8% the third dose. By contrast,
only 59.7% of children received the first dose of MMR on time com-Fig. 2. Age at vaccination (A) Age at DTP 1 vaccination (B) Age at MMR 1 vaccipared with 79.7% for the first dose of DTP (Fig. 1B). Similar patterns
were observed for the primary doses of Men C and Hib (Appendix
2).
Based on Department of Health guidance that the first doses of
primary vaccines can be given from six weeks of age, very few chil-
dren received vaccines so early as to be considered ineffective [13].nation (showing 0–3 years) (C) Age at DTP pre-school booster vaccination.
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seven weeks of age.
Delay in vaccination varied according to the vaccine and dose.
For example, 30% of children with delayed DTP 1 were more than
four weeks late (Fig. 2A), increasing to 38% and 47% for DTP 2
and DTP 3 respectively. Similarly for MMR 1, for 55% of those
delayed, it was by more than three months (Fig. 2B), with some
children (n = 51) not vaccinated until age 11 or 12 years, the major-
ity during a measles outbreak. Pre-school boosters were more than
six months late in two thirds of children with delay (Fig. 2C).
Timeliness of Men C vaccination decreased with vaccine dose
(Fig. 3), with 94%, 81% and 65% vaccinated early or on time
(weighted percentages) for the first, second and third doses respec-
tively (Appendix 2). Similar patterns were observed for DTP, polio
and Hib (data not shown).
Uptake of the second dose of MMR, although slightly lower,
mirrored that of polio (Fig. 4). This shows that unlike the primary
immunisations, pre-school boosters were not given uniformly over
the period when vaccines were due. It suggests differing practices,
with some immunised as soon as the vaccines were due whilst
others were immunised at four years of age. Catch up of pre-Fig. 3. Age children recei
Fig. 4. Age children received theschool boosters continued throughout childhood, and eventually,
uptake of the second dose of MMR equalled that of polio.
3.4. Time intervals between doses
Although the median interval between the first and second
doses was comparable to the recommended schedule, there was
considerable variability between children in minimum and maxi-
mum intervals, with the median intervals between the second
and third doses of the primary immunisations exceeding the rec-
ommendations (Fig. 5; Appendix 3).
3.5. Factors associated with delayed primary vaccinations
Boys (5.8%) were more likely than girls (3.7%) to have received
the first dose of DTP late (p = .045). Delay of the first dose of DTP
was also significantly associated with: larger family size (11.5%
delayed where four or more children in the household, compared
with 2.5% where only child in the household, p = .0001); lower
maternal academic qualifications (8.9% of those whose mothers
had no academic qualifications delayed compared with 1.2% ofved Men C vaccines.
pre-school booster vaccines.
Fig. 5. Boxplots of time between vaccine doses (A) weeks between DTP 1 and DTP 2 (recommended interval 4 weeks) (B) years between DTP 3 and DTP pre-school booster
(recommended interval 3 years).
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ployment (6.7% of those whose mother was not in work or on leave
delayed compared with 3.0% where mother in work or on leave, p
= .0016).4. Discussion
This is the first UK study using linked cohort and routine immu-
nisation data to explore uptake and timeliness of childhood vacci-
nation in a nationally representative sample. Routine community
child health data contain rich information on the timeliness of vac-
cination and we have demonstrated the completeness and use of
this to understand the distribution of delayed primary and pre-
school vaccinations in a large sample of children.
Uptake of the first doses of all the primary vaccines was high
and similar with around 94% given early or on time (Appendix
2). However, timeliness decreased with the number of subsequent
doses and timeliness of the first dose of MMR vaccine was notably
worse than for other vaccines. Similarly, the proportion of children
with delayed receipt of vaccines increased with subsequent doses,
amplifying the risks associated with incomplete vaccination. These
findings are consistent with those reported by Hull and McIntyre inAustralia [2]. The proportion of children not vaccinated at all (up to
the age of 14 years) ranged from 0.8% for the primary course of
polio to 6.3% for the DTP pre-school booster. Delay of the primary
vaccinations was associated with larger family size, lower mater-
nal academic qualifications andmaternal unemployment. This sug-
gests delayed vaccination may be associated with deprivation in
turn reflecting challenges accessing services in a timely manner
due to other pressures.
Our finding that the timeliness of the first dose of MMR was
poorer than that of other vaccines was unsurprising as these chil-
dren were due to have their MMR vaccine in 2001–2, at the peak of
public anxiety over the vaccine’s safety triggered by the now dis-
credited 1998 Lancet publication [14]. By the time the second dose
of MMR was given (2004 onwards) confidence appears to have
improved; 80% received MMR 2 on time and during the period
the vaccines were due, for any given age, uptake of MMR 2 was
only a few percentage points lower than that for the pre-school
boosters. COVER data also reflects the improvement in uptake of
the second MMR dose by 2004 [15].
Any delay in receiving scheduled vaccines leaves children inad-
equately protected and at risk of infectious diseases compromising
both their own protection and population immunity. We found
that some children were at risk of potentially severe infections
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first dose of MMR when they were aged 11 or 12 years, and for
the majority of these, this appeared to be in response to a large
measles outbreak in Wales between November 2012 and July
2013 [16].
The strengths of this study are that it was based on a nationally
representative sample, used routine health records with a high
proportion of parents consenting to record linkage and a high pro-
portion of records were successfully linked. The completeness of
NCCHD records and the triangulation with parental report showing
agreement demonstrates good quality data in routine records and
increased the validity of our findings.
This cohort of children received separate DTP, polio, and Hib
vaccines rather than the 5-in-1 vaccine introduced in 2004 or the
6-in-1 vaccine introduced in 2017. Whilst the majority of children
received the separate vaccines on the same occasion as intended
and parents did not omit or delay specific vaccines, we would still
anticipate improved vaccine uptake since the introduction of the
combination vaccines.
We were not able to calculate exact ages at vaccination as day of
birth was withheld to minimise risk of disclosure. As birth day was
allocated randomly this should not have affected the proportions
of vaccines estimated to be early, on-time or delayed.
Overall the quality of the NCCHD records was good, an impor-
tant requirement for effective monitoring of vaccine uptake [17].
Errors in NCCHD vaccination records were identified for 40 (2.2%)
children, and were mainly due to recording two doses of MMR 2
and none for MMR 1, perhaps reflecting confusion due to the vac-
cine trade name MMR II, or that when a child has their first MMR
vaccine at an older age it is coded as the second instead of the first.
Additionally, we questioned the accuracy of some data which may
or may not have been data entry errors. For example, doses given
very early or with a reduced gap may represent a data entry error,
atypical practice or atypical circumstances.
Tickner’s study of parental views about pre-school immunisa-
tion, reported some found it harder taking older and thus more
aware children for vaccination. Parents also reported less contact
with health visitors when pre-school boosters and second MMR
doses are due and the lack of information provided to them, made
them question their importance [18]. Although, immunisation
reminders are highly effective at increasing uptake [19] parents
may also need a more personalised approach to be reminded of
the continued importance of immunisation in older children.
Recently, an increase in use of alternative vaccine schedules (inten-
tional deviation from the routine schedule) has been reported from
the USA which include delay in commencing, rejection of some
vaccines and spacing of others [20]. We suspect this is unlikely
to have been a significant factor in this population, but as estima-
tion of vaccination timeliness in UK is not routinely conducted, this
cannot currently be monitored.
Previous studies of immunisation uptake from the same cohort
and based on parental report suggested high immunisation uptake
in the cohort participants. Using data from the first interview at
age nine months, Samad et al. reported that 95.6% of all MCS
infants were fully immunised [8]. Our data showed that at nine
months (39 weeks) of age, 94% of Welsh infants had received three
doses of DTP, Men C, Hib and polio according to NCCHD records.
Similarly, using data from the age three MCS interview, Pearce
et al. reported that 88.6% of participants had received MMR vaccine
(10, 21) this compares with our finding that 88.2% of Welsh partic-
ipants received their first dose of MMR by three years of age
according to NCCHD records. While these earlier studies included
the whole UK MCS population (and differences were noted
between countries), and participants were not exactly nine months
or three years of age at the interviews, uptake rates based on par-
ental report and on health service data are similar. Additionally wedemonstrated high levels of concordance between parental report
and health records, of MMR immunisation status with even better
agreement when parents refer to the PCHR. Where there are dis-
crepancies, errors may lie in either parental recall or in the entries
in the health records [22]. In contrast with the findings of a recent
systematic review [21], we found parental report of immunisation
uptake to be reliable.
Hull and McIntyre [2] propose that with high vaccine coverage
achieved in most industrialised countries, vaccination timeliness is
the ‘‘next benchmark to aim for in programme performance”.
Although our analysis using routine data in Wales is not based
on a current cohort of children and hence estimates of timeliness
may not reflect current practice, we have demonstrated the value
of exploring this measure. Although Scotland publishes timeliness
of primary and MMR vaccines by deprivation [23], it is not easy to
conduct the same analysis for the whole of the UK as England does
not currently have a unified child health database. We are conduct-
ing further work based on the linked MCS and NCCHD records to
investigate further those factors associated with vaccine delay to
inform policy and practice. Timely immunisation is important to
provide children with maximum protection against serious infec-
tious diseases. We have demonstrated the feasibility and value of
using routine child health data to explore vaccine timeliness and
recommend that in addition to vaccine coverage, a measure of vac-
cination timeliness is used routinely to evaluate the quality of
immunisation services.Acknowledgements
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